Spondyloarthropathy: interleukin 23 and disease modification

Lancet. 2015 May 23;385(9982):2017-8. doi: 10.1016/S0140-6736(15)60970-9.
No abstract available

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Humans
  • Interleukin-23 / therapeutic use*
  • Spondylarthropathies / drug therapy*

Substances

  • Antirheumatic Agents
  • Interleukin-23